Table 3 Baseline laboratory findings of female and male patients infected with SARS-CoV-2

White blood cell count, × 10^{^}9/L

5.6 (4.4–7.8)

5.2 (4.1–7.5)

5.8 (4.8–8.0)

0.045

Neutrophil count, × 10^{^}9/L

4.0 (2.9–6.3)

3.6 (2.6–5.9)

4.3 (3.1–6.4)

0.024

Lymphocyte count, × 10^{^}9/L

0.9 (0.6–1.3)

1.0 (0.7–1.3)

0.8 (0.6–1.1)

0.45

Hemoglobin, g/L

127.0 (116.0–139.0)

120.0 (112.0–128.0)

136.0 (125.8–144.0)

< 0.001

Platelet count, ×10^{^}9/L

208.0 (154.0–285.0)

233.0 (164.0–307.0)

190.0 (141.8–254.0)

< 0.001

Albumin, g/L

33.7 (30.8–36.8)

34.0 (31.3–37.8)

33.4 (30.2–36.1)

0.037

Blood bicarbonate ions, mmol/L

23.5 (21.7–25.1)

23.8 (21.8–25.5)

23.3 (21.6–24.8)

0.231

Blood urea nitrogen, mmol/L

4.6 (3.5–6.0)

4.2 (3.2–5.3)

4.9 (3.8–6.5)

< 0.001

Blood creatinine, μmol/L

70.0 (57.5–86.0)

58.0 (52.0–70.0)

81.0 (68.0–95.0)

< 0.001

Lactate dehydrogenase, U/L

302.0 (237.0–425.0)

272.0 (223.0–345.0)

324.0 (254.0–471.5)

< 0.001

High-sensitivity C-reactive protein, mg/L

41.1 (11.8–90.6)

23.4 (7.1–69.3)

66.0 (25.9–121.4)

< 0.001

Procalcitonin, ng/mL

0.06 (0.03–0.17)

0.04 (0.02–0.09)

0.09 (0.05–0.23)

< 0.001

Ferritin, μg/L

751.5 (435.7–1333.9)

533.2 (264.8–932.6)

1069.85 (611.4–1734.2)

< 0.001

Soluble interlukin-2 receptor, U/mL

762.0 (509.9–1124.0)

678.0 (501.0–1023.0)

879.0 (625.8–1232.0)

0.001

Interleukin-6, pg/mL

21.7 (7.3–53.9)

15.2 (3.9–40.0)

33.0 (12.0–68.5)

< 0.001

Interleukin-8, pg/mL

15.5 (9.4–26.6)

15.1 (9.2–26.0)

16.0 (9.6–28.2)

0.261

Interleukin-10, pg/mL

5.6 (5.00–9.4)

5.0 (5.0–8.5)

6.6 (5.0–10.2)

0.12

Tumor necrosis factor alpha, pg/mL

9.1 (7.2–12.1)

8.7 (6.8–11.6)

9.7 (7.6–13.0)

0.093